Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome | Request PDF
CRISPR gene editing - Wikipedia
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy | Nature Medicine
CRISPR algorithm predicts how well gene editing will work - Scope
Four U.S. CRISPR Trials Editing Human DNA to Research New Treatments | Science | Smithsonian Magazine
CRISPR-Edited Cells Linked to Cancer Risk in 2 Studies - Scientific American
Focus on CRISPR tools and therapies | Nature Biotechnology
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects | Signal Transduction and Targeted Therapy
PDF) The CRISPR tool kit for genome editing and beyond
Nature Medicine》基因编辑工具增加致癌隐患- 生物通
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development
First Trial of CRISPR-Edited T cells in Lung Cancer: Trends in Molecular Medicine
CRISPR, the disruptor : Nature News & Comment
Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL
CRISPR-Cas 9 corrects genetic defects in mice
First CRISPR editing trial results assuage safety concerns
Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors
Kill Switch for CRISPR Could Make Gene Editing Safer - Scientific American
CRISPR-engineered T cells in patients with refractory cancer | Science
Is Crispr the Next Antibiotic? - The New York Times
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
